Sanofi Consumer Healthcare India Limited (NSE:SANOFICONR)
India flag India · Delayed Price · Currency is INR
5,158.00
+65.20 (1.28%)
At close: Aug 14, 2025, 3:30 PM IST

NSE:SANOFICONR Income Statement

Millions INR. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023
Period Ending
Jun '25 Dec '24 Dec '23
Revenue
7,2417,2458,331
Revenue Growth (YoY)
-13.08%-13.04%-
Cost of Revenue
1,8221,8772,291
Gross Profit
5,4195,3686,041
Selling, General & Admin
1,3741,2351,050
Other Operating Expenses
1,4511,4271,709
Operating Expenses
2,9002,7072,786
Operating Income
2,5192,6613,255
Interest Expense
-47-39-
Interest & Investment Income
11811860
Currency Exchange Gain (Loss)
11-
Other Non Operating Income (Expenses)
81111.5
EBT Excluding Unusual Items
2,6722,7523,317
Asset Writedown
-29-29-
Other Unusual Items
54-255-27
Pretax Income
2,6972,4683,290
Income Tax Expense
697658816
Net Income
2,0001,8102,474
Net Income to Common
2,0001,8102,474
Net Income Growth
-19.14%-26.82%-
Shares Outstanding (Basic)
232323
Shares Outstanding (Diluted)
232323
EPS (Basic)
86.8478.59107.40
EPS (Diluted)
86.8478.59107.40
EPS Growth
-19.14%-26.82%-
Free Cash Flow
2,0884,291-66
Free Cash Flow Per Share
90.66186.32-2.87
Dividend Per Share
-55.000-
Gross Margin
74.84%74.09%72.51%
Operating Margin
34.79%36.73%39.07%
Profit Margin
27.62%24.98%29.69%
Free Cash Flow Margin
28.84%59.23%-0.79%
EBITDA
2,5712,6833,282
EBITDA Margin
35.51%37.03%39.40%
D&A For EBITDA
522227
EBIT
2,5192,6613,255
EBIT Margin
34.79%36.73%39.07%
Effective Tax Rate
25.84%26.66%24.81%
Revenue as Reported
7,4417,3758,393
Advertising Expenses
-181-
Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.